Showing results (821-830 of 1,628) with videos related to

Sort By:
Pageof 163
The International Journal of Biological Markers|August 5, 2025
Circular RNA PVT1 as a potential biomarker for human cancers: A systematic review and meta-analysisXiaoyan Ma, Junheng Chen, Chunbin Zhou
The International Journal of Biological Markers|February 19, 2026
High KAP1 expression promotes pleural mesothelioma cell proliferation and metastasisWen Mei, Yiqi Wang, Shengjie Yang, et al.
The International Journal of Biological Markers|March 2, 2026
Causal association between oxidative stress and lymphomas: A two-sample Mendelian randomization studyBin Zhu, Wenli Zhao
The International Journal of Biological Markers|March 2, 2026
LINC00578 as a prognostic biomarker in lung adenocarcinoma via regulation of miR-153-5pWenju Pan, Jun Hong, Mingwei Zhang, et al.
The International Journal of Biological Markers|October 17, 2023
Systematic analysis reveals distinct roles of USF family proteins in various cancer typesXia Liu, Zhuo-Zhi Wang, Shuai Meng, et al.
The International Journal of Biological Markers|November 7, 2023
Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinomaZongkai Zhang, Yin Li, Ying Wu, et al.
The International Journal of Biological Markers|September 13, 2023
The clinical and pathological significance of increased expression of the cannabinoid receptors CB-1R and CB-2R in patients with papillary thyroid carcinomas compared to benign thyroid lesionsDamla Zeynep Doyuran, Ömer Eronat
The International Journal of Biological Markers|April 12, 2026
Single-cell RNA sequencing analysis reveals cellular heterogeneity and immune microenvironment dynamics in colorectal cancerJin-Liang Zhu, Hong-Jian Gao, Lu-Ji Qiao, et al.
The International Journal of Biological Markers|December 20, 2012
Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumorsLan-jun Bai, Qing Liu, Min Wang, et al.
The International Journal of Biological Markers|July 3, 2026
PFKP: A biomarker for prognosis, response to treatment and immune function of breast cancerKatie-Rose Cawthorne, Alistair Heath, Vijay Sharma
Pageof 163